グローバルエポジェンとバイオシミラー市場規模、主要企業シェア、ランキング分析レポート【2026年版】

Epogen and Biosimilar - Global Top Players Market Share and Ranking 2026

レポートID：
191303
発表時期：
2026-02-06
レポート形式：
PDF
産業カテゴリー：
医療機器と消耗材
レポート言語：
英語、日本語
ページ数：
98
発行会社（調査会社）：
YHResearch

レポートの概要

本報告書は、世界のエポジェンとバイオシミラー市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点からエポジェンとバイオシミラー市場を分析し、需要構造と成長特性を明確化します。
エポジェンとバイオシミラー市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、エポジェンとバイオシミラーに関する的確な意思決定を行うための実践的なインサイトを提供します。

 主要エポジェンとバイオシミラー市場の統計
2025年世界市場規模：650百万米ドル
2026年世界市場規模：632百万米ドル
2032年予測市場規模：528百万米ドル
2026–2032年予測期間CAGR：-2.95%
本レポートはエポジェンとバイオシミラー市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
エポジェンとバイオシミラー市場の主要企業には以下が含まれます：
Amgen
Pfizer 

製品別
Brand
Biosimilar 

アプリケーション別
Hospital
Pharmacy
Other 

レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他

レポート構成（章別概要）
第1章｜市場概要と成長展望
エポジェンとバイオシミラー市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
エポジェンとバイオシミラー市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別にエポジェンとバイオシミラー市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別にエポジェンとバイオシミラー市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、エポジェンとバイオシミラー市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、エポジェンとバイオシミラー市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
エポジェンとバイオシミラー市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
 エポジェンとバイオシミラー市場の全体像と成長見通し
エポジェンとバイオシミラー市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境がエポジェンとバイオシミラー市場に与える影響を分析いたします
 市場環境の構成要素とマクロトレンド
エポジェンとバイオシミラー産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
 競争構造と主要企業の動向分析
エポジェンとバイオシミラー市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
 競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点からエポジェンとバイオシミラー市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
 成長要因・課題・リスクの分析
エポジェンとバイオシミラー市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
 将来トレンドと市場展望
エポジェンとバイオシミラー市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします

Description

According to YH Research, the global market for Epogen and Biosimilar should grow from US$ 650 million in 2025 to US$ 528 million by 2032, with a CAGR of -3.0% for the period of 2026-2032.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

EPOGEN® is a prescription medication that is used to treat anemia for people with CKD on dialysis by helping the body create more red blood cells.

By country, Japan accounted for percent of the global market last year and Japan’s market share increased from percent to percent. Japan Epogen and Biosimilar market should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of % for the period of 2026-2032. The United States Epogen and Biosimilar market should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of % for the period of 2026-2032.

By segment, Hospital grew percent to account for percent of the total market sales, and Pharmacy grew percent.

This report studies and analyses global Epogen and Biosimilar status and future trends, helps the client to determine the Epogen and Biosimilar market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Epogen and Biosimilar, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Epogen and Biosimilar market size, history data 2021-2025, and forecast data 2026-2032, (US$ million) & (K Units)
(2) Global Epogen and Biosimilar sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (K Units)
(3) Japan Epogen and Biosimilar sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (K Units)
(4) Global Epogen and Biosimilar key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Epogen and Biosimilar key producing regions, capacity, production, and year over year growth
(6) Epogen and Biosimilar industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Amgen
    Pfizer

Market segment by Type, covers
    Brand
    Biosimilar

Market segment by Application, can be divided into
    Hospital
    Pharmacy
    Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Epogen and Biosimilar product scope, global sales quantity, value and average price, Japan sales quantity, value and average price, development opportunities, challenges, trends, and policies
Chapter 2: Global Epogen and Biosimilar market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 3: Japan Epogen and Biosimilar market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 4: Global key producing regions of Epogen and Biosimilar, percent & CAGR, 2021-2032
Chapter 5: Epogen and Biosimilar industry chain, upstream, medium-stream, and downstream
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin
Chapter 11: Conclusions

Table of Contents

1 Market Overview
    1.1 Epogen and Biosimilar Definition
    1.2 Global Epogen and Biosimilar Market Size and Forecast
        1.2.1 By Consumption Value, Global Epogen and Biosimilar Market Size, 2021-2032
        1.2.2 By Sales Quantity, Global Epogen and Biosimilar Market Size, 2021-2032
        1.2.3 Global Epogen and Biosimilar Average Selling Price (ASP), 2021-2032
    1.3 Japan Epogen and Biosimilar Market Size and Forecast
        1.3.1 By Consumption Value, Japan Epogen and Biosimilar Market Size, 2021-2032
        1.3.2 By Sales Quantity, Japan Epogen and Biosimilar Market Size, 2021-2032
        1.3.3 Japan Epogen and Biosimilar Average Selling Price (ASP), 2021-2032
    1.4 Share of Japan Epogen and Biosimilar Market with Respect to the Global Market
        1.4.1 By Consumption Value, Japan Epogen and Biosimilar Market Share in Global, 2021-2032
        1.4.2 By Sales Quantity, Japan Epogen and Biosimilar Market Share in Global, 2021-2032
        1.4.3 Epogen and Biosimilar Market Size: Japan VS Global, 2021-2032
    1.5 Epogen and Biosimilar Market Dynamics
        1.5.1 Epogen and Biosimilar Market Drivers
        1.5.2 Epogen and Biosimilar Market Restraints
        1.5.3 Epogen and Biosimilar Industry Trends
        1.5.4 Epogen and Biosimilar Industry Policy

2 Global Leading Manufacturers and Market Share
    2.1 By Revenue of Epogen and Biosimilar, Global Market Share by Company, 2021-2026
    2.2 By Sales Quantity of Epogen and Biosimilar, Global Market Share by Company, 2021-2026
    2.3 Epogen and Biosimilar Average Selling Price (ASP) by Company, 2021-2026
    2.4 Global Epogen and Biosimilar Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.5 Global Epogen and Biosimilar Concentration Ratio
    2.6 Global Epogen and Biosimilar Mergers & Acquisitions, Expansion Plans
    2.7 Global Epogen and Biosimilar Manufacturers Product Type
    2.8 Head Office and Epogen and Biosimilar Production Site of Key Manufacturer
    2.9 Epogen and Biosimilar Capacity of Major Manufacturers and Future Plan

3 Japan Leading Manufacturers and Market Share
    3.1 By Revenue of Epogen and Biosimilar, Japan Market Share by Company, 2021-2026
    3.2 By Sales Quantity of Epogen and Biosimilar, Japan Market Share by Company, 2021-2026
    3.3 Japan Epogen and Biosimilar Epogen and Biosimilar Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
    4.1 Global Epogen and Biosimilar Capacity, Output and Capacity Utilization, 2021-2032
    4.2 Global Epogen and Biosimilar Capacity by Region
    4.3 Global Epogen and Biosimilar Production & Forecast by Region, 2021 VS 2025 VS 2032
    4.4 Global Epogen and Biosimilar Production by Region, 2021-2032
    4.5 Global Epogen and Biosimilar Production Market Share & Forecast by Region, 2021-2032

5 Industry Chain Analysis
    5.1 Epogen and Biosimilar Industry Chain
    5.2 Epogen and Biosimilar Upstream Analysis
        5.2.1 Epogen and Biosimilar Core Raw Materials
        5.2.2 Main Manufacturers of Epogen and Biosimilar Core Raw Materials
    5.3 Midstream Analysis
    5.4 Downstream Analysis
    5.5 Epogen and Biosimilar Production Mode
    5.6 Epogen and Biosimilar Procurement Model
    5.7 Epogen and Biosimilar Industry Sales Model and Sales Channels
        5.7.1 Epogen and Biosimilar Sales Model
        5.7.2 Epogen and Biosimilar Typical Distributors

6 Sights by Type
    6.1 Epogen and Biosimilar Classification by Type
        6.1.1 Brand
        6.1.2 Biosimilar
    6.2 by Type, Global Epogen and Biosimilar Consumption Value & CAGR, 2021 VS 2025 VS 2032
    6.3 by Type, Global Epogen and Biosimilar Consumption Value, 2021-2032
    6.4 by Type, Global Epogen and Biosimilar Sales Quantity, 2021-2032
    6.5 by Type, Global Epogen and Biosimilar Average Selling Price (ASP), 2021-2032

7 Sights by Application
    7.1 Epogen and Biosimilar Segment by Application
        7.1.1 Hospital
        7.1.2 Pharmacy
        7.1.3 Other
    7.2 by Application, Global Epogen and Biosimilar Consumption Value & CAGR, 2021 VS 2025 VS 2032
    7.3 by Application, Global Epogen and Biosimilar Consumption Value, 2021-2032
    7.4 by Application, Global Epogen and Biosimilar Sales Quantity, 2021-2032
    7.5 by Application, Global Epogen and Biosimilar Price, 2021-2032

8 Sales Sights by Region
    8.1 By Region, Global Epogen and Biosimilar Consumption Value, 2021 VS 2025 VS 2032
    8.2 By Region, Global Epogen and Biosimilar Consumption Value, 2021-2032
    8.3 By Region, Global Epogen and Biosimilar Sales Quantity, 2021-2032
    8.4 North America
        8.4.1 North America Epogen and Biosimilar Market Size & Forecasts, 2021-2032
        8.4.2 By Country, North America Epogen and Biosimilar Market Size Market Share
    8.5 Europe
        8.5.1 Europe Epogen and Biosimilar Market Size & Forecasts, 2021-2032
        8.5.2 By Country, Europe Epogen and Biosimilar Market Size Market Share
    8.6 Asia Pacific
        8.6.1 Asia Pacific Epogen and Biosimilar Market Size & Forecasts, 2021-2032
        8.6.2 By Country/Region, Asia Pacific Epogen and Biosimilar Market Size Market Share
    8.7 South America
        8.7.1 South America Epogen and Biosimilar Market Size & Forecasts, 2021-2032
        8.7.2 By Country, South America Epogen and Biosimilar Market Size Market Share
    8.8 Middle East & Africa

9 Sales Sights by Country Level
    9.1 By Country, Global Epogen and Biosimilar Market Size & CAGR, 2021 VS 2025 VS 2032
    9.2 By Country, Global Epogen and Biosimilar Consumption Value, 2021-2032
    9.3 By Country, Global Epogen and Biosimilar Sales Quantity, 2021-2032
    9.4 United States
        9.4.1 United States Epogen and Biosimilar Market Size, 2021-2032
        9.4.2 by Type, United States Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
        9.4.3 by Application, United States Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
    9.5 Europe
        9.5.1 Europe Epogen and Biosimilar Market Size, 2021-2032
        9.5.2 by Type, Europe Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
        9.5.3 by Application, Europe Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
    9.6 China
        9.6.1 China Epogen and Biosimilar Market Size, 2021-2032
        9.6.2 by Type, China Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
        9.6.3 by Application, China Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
    9.7 Japan
        9.7.1 Japan Epogen and Biosimilar Market Size, 2021-2032
        9.7.2 by Type, Japan Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
        9.7.3 by Application, Japan Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
    9.8 South Korea
        9.8.1 South Korea Epogen and Biosimilar Market Size, 2021-2032
        9.8.2 by Type, South Korea Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
        9.8.3 by Application, South Korea Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
    9.9 Southeast Asia
        9.9.1 Southeast Asia Epogen and Biosimilar Market Size, 2021-2032
        9.9.2 by Type, Southeast Asia Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
        9.9.3 by Application, Southeast Asia Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
    9.10 India
        9.10.1 India Epogen and Biosimilar Market Size, 2021-2032
        9.10.2 by Type, India Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
        9.10.3 by Application, India Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
    9.11 Middle East & Africa
        9.11.1 Middle East & Africa Epogen and Biosimilar Market Size, 2021-2032
        9.11.2 by Type, Middle East & Africa Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
        9.11.3 by Application, Middle East & Africa Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032

10 Manufacturers Profile
    10.1 Amgen
        10.1.1 Amgen Company Information, Head Office, Market Area, and Industry Position
        10.1.2 Amgen Epogen and Biosimilar Models, Specifications, and Application
        10.1.3 Amgen Epogen and Biosimilar Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.1.4 Amgen Company Profile and Main Business
        10.1.5 Amgen Recent Developments
    10.2 Pfizer
        10.2.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
        10.2.2 Pfizer Epogen and Biosimilar Models, Specifications, and Application
        10.2.3 Pfizer Epogen and Biosimilar Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.2.4 Pfizer Company Profile and Main Business
        10.2.5 Pfizer Recent Developments

11 Conclusion

12 Appendix
    12.1 Research Methodology
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Market Estimation Model
    12.4 Disclaimer

Table of Figures

List of Tables
Table 1. Epogen and Biosimilar Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million
Table 2. Epogen and Biosimilar Market Restraints
Table 3. Epogen and Biosimilar Market Trends
Table 4. Epogen and Biosimilar Industry Policy
Table 5. Global Epogen and Biosimilar Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
Table 6. Global Epogen and Biosimilar Revenue Share by Company, 2021-2026, Ranked by Data of 2025
Table 7. Global Epogen and Biosimilar Sales Quantity by Company, (2021-2026) & (K Units), Ranked Based on Sales in 2025
Table 8. Global Epogen and Biosimilar Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025
Table 9. Global Epogen and Biosimilar Average Selling Price (ASP) by Company, (2021-2026) & (US$/Unit)
Table 10. Global Epogen and Biosimilar Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Epogen and Biosimilar Mergers & Acquisitions, Expansion Plans
Table 12. Global Epogen and Biosimilar Manufacturers Product Type
Table 13. Head Office and Epogen and Biosimilar Production Site of Key Manufacturer
Table 14. Epogen and Biosimilar Capacity of Major Manufacturers and Future Plan
Table 15. Japan Epogen and Biosimilar Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
Table 16. Japan Epogen and Biosimilar Revenue Share by Company, 2021-2026, Ranked by Data of 2025
Table 17. Japan Epogen and Biosimilar Sales Quantity by Company, (2021-2026) & (K Units), Ranked Based on Sales in 2025
Table 18. Japan Epogen and Biosimilar Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025
Table 19. Global Epogen and Biosimilar Production & Forecast by Region, 2021 VS 2025 VS 2032, (K Units)
Table 20. Global Epogen and Biosimilar Production by Region, 2021-2026, (K Units)
Table 21. Global Epogen and Biosimilar Production Forecast by Region, 2027-2032, (K Units)
Table 22. Global Key Players of Epogen and Biosimilar Upstream (Raw Materials)
Table 23. Global Epogen and Biosimilar Typical Customers
Table 24. Epogen and Biosimilar Typical Distributors
Table 25. by Type, Global Epogen and Biosimilar Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
Table 26. by Application, Global Epogen and Biosimilar Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
Table 27. By Region, Global Epogen and Biosimilar Consumption Value, 2021 VS 2025 VS 2032, US$ Million
Table 28. By Region, Global Epogen and Biosimilar Consumption Value, 2021-2032, US$ Million
Table 29. By Region, Global Epogen and Biosimilar Sales Quantity, 2021-2032, (K Units)
Table 30. By Country, Global Epogen and Biosimilar Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
Table 31. By Country, Global Epogen and Biosimilar Consumption Value, 2021-2032, US$ Million
Table 32. By Country, Global Epogen and Biosimilar Consumption Value Market Share, 2021-2032
Table 33. By Country, Global Epogen and Biosimilar Sales Quantity, 2021-2032, (K Units)
Table 34. By Country, Global Epogen and Biosimilar Sales Quantity Market Share, 2021-2032
Table 35. Amgen Company Information, Head Office, Market Area, and Industry Position
Table 36. Amgen Epogen and Biosimilar Models, Specifications, and Application
Table 37. Amgen Epogen and Biosimilar Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 38. Amgen Company Profile and Main Business
Table 39. Amgen Recent Developments
Table 40. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 41. Pfizer Epogen and Biosimilar Models, Specifications, and Application
Table 42. Pfizer Epogen and Biosimilar Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 43. Pfizer Company Profile and Main Business
Table 44. Pfizer Recent Developments

List of Figures
Figure 1. Epogen and Biosimilar Picture
Figure 2. Global Epogen and Biosimilar Consumption Value, (US$ million) & (2021-2032)
Figure 3. Global Epogen and Biosimilar Sales Quantity, (K Units) & (2021-2032)
Figure 4. Global Epogen and Biosimilar Average Selling Price (ASP), (2021-2032) & (US$/Unit)
Figure 5. Japan Epogen and Biosimilar Consumption Value, (US$ million) & (2021-2032)
Figure 6. Japan Epogen and Biosimilar Sales Quantity (K Units) & (2021-2032)
Figure 7. Japan Epogen and Biosimilar Average Selling Price (ASP), (US$/Unit) & (2021-2032)
Figure 8. By Consumption Value, Japan Epogen and Biosimilar Market Share of Global, 2021-2032
Figure 9. By Sales Quantity, Japan Epogen and Biosimilar Market Share of Global, 2021-2032
Figure 10. Global Epogen and Biosimilar Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025
Figure 11. Japan Epogen and Biosimilar Key Participants, Market Share, 2025
Figure 12. Global Epogen and Biosimilar Capacity, Production and Capacity Utilization, 2021-2032
Figure 13. Global Epogen and Biosimilar Capacity Market Share by Region, 2025 VS 2032
Figure 14. Global Epogen and Biosimilar Production Market Share & Forecast by Region, 2021-2032
Figure 15. Epogen and Biosimilar Industry Chain
Figure 16. Epogen and Biosimilar Procurement Model
Figure 17. Epogen and Biosimilar Sales Model
Figure 18. Epogen and Biosimilar Sales Channels, Direct Sales, and Distribution
Figure 19. Brand
Figure 20. Biosimilar
Figure 21. by Type, Global Epogen and Biosimilar Consumption Value, 2021-2032, US$ Million
Figure 22. by Type, Global Epogen and Biosimilar Consumption Value Market Share, 2021-2032
Figure 23. by Type, Global Epogen and Biosimilar Sales Quantity, 2021-2032, (K Units)
Figure 24. by Type, Global Epogen and Biosimilar Sales Quantity Market Share, 2021-2032
Figure 25. by Type, Global Epogen and Biosimilar Average Selling Price (ASP), 2021-2032, (US$/Unit)
Figure 26. Hospital
Figure 27. Pharmacy
Figure 28. Other
Figure 29. by Application, Global Epogen and Biosimilar Consumption Value, 2021-2032, US$ Million
Figure 30. by Application, Global Epogen and Biosimilar Revenue Market Share, 2021-2032
Figure 31. by Application, Global Epogen and Biosimilar Sales Quantity, 2021-2032, (K Units)
Figure 32. by Application, Global Epogen and Biosimilar Sales Quantity Market Share, 2021-2032
Figure 33. by Application, Global Epogen and Biosimilar Price, 2021-2032, (US$/Unit)
Figure 34. By Region, Global Epogen and Biosimilar Consumption Value Market Share, 2021-2032
Figure 35. By Region, Global Epogen and Biosimilar Sales Quantity Market Share, 2021-2032
Figure 36. North America Epogen and Biosimilar Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 37. By Country, North America Epogen and Biosimilar Consumption Value Market Share, 2025
Figure 38. Europe Epogen and Biosimilar Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 39. By Country, Europe Epogen and Biosimilar Consumption Value Market Share, 2025
Figure 40. Asia Pacific Epogen and Biosimilar Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 41. By Country/Region, Asia Pacific Epogen and Biosimilar Consumption Value Market Share, 2025
Figure 42. South America Epogen and Biosimilar Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 43. By Country, South America Epogen and Biosimilar Consumption Value Market Share, 2025
Figure 44. Middle East & Africa Epogen and Biosimilar Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 45. United States Epogen and Biosimilar Sales Quantity, 2021-2032, (K Units)
Figure 46. by Type, United States Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 47. by Application, United States Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 48. Europe Epogen and Biosimilar Sales Quantity, 2021-2032, (K Units)
Figure 49. by Type, Europe Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 50. by Application, Europe Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 51. China Epogen and Biosimilar Sales Quantity, 2021-2032, (K Units)
Figure 52. by Type, China Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 53. by Application, China Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 54. Japan Epogen and Biosimilar Sales Quantity, 2021-2032, (K Units)
Figure 55. by Type, Japan Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 56. by Application, Japan Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 57. South Korea Epogen and Biosimilar Sales Quantity, 2021-2032, (K Units)
Figure 58. by Type, South Korea Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 59. by Application, South Korea Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 60. Southeast Asia Epogen and Biosimilar Sales Quantity, 2021-2032, (K Units)
Figure 61. by Type, Southeast Asia Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 62. by Application, Southeast Asia Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 63. India Epogen and Biosimilar Sales Quantity, 2021-2032, (K Units)
Figure 64. by Type, India Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 65. by Application, India Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 66. Middle East & Africa Epogen and Biosimilar Sales Quantity, 2021-2032, (K Units)
Figure 67. by Type, Middle East & Africa Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 68. by Application, Middle East & Africa Epogen and Biosimilar Sales Quantity Market Share, 2025 VS 2032
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up Approaches
Figure 72. Top-down Approaches

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット

購入方法

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）